Medtronic PLC has acquired Bellco, which creates therapies and systems for the treatment of renal failure, multiple organ failure and sepsis. Medtornic recently formed a renal care solutions business.
Bellco’s line of dialyzers and chronic and acute dialysis machines perform dialysis for adult, pediatric and neonatal ESRD patients, and are available in more than 50 countries.
Read also: Medtronic device gets CE mark for AV access in dialysis patients
The device aids in preventing restenosis in dialysis patients’ access sites by opening the artery and delivering paclitaxel, an anti-proliferative agent, to the vessel wall. More
“The integration of Bellco’s portfolio of solutions will help further advance Medtronic’s efforts to provide comprehensive care for dialysis patients worldwide,” said Ven Manda, president of Renal Care Solutions, Medtronic.
Medtronic acquired Bellco, an Italian-based company, from Charme Capital Partners, manager of the pan-European Charme Funds. Terms of the acquisition were not disclosed.